Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
09 Agosto 2023 - 2:00PM
Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer
of critical reagents for the research, development, and
commercialization of novel therapies, vaccines, and molecular
diagnostics, today announced the opening of their newest
GMP-certified production facility, enabling bioprocessing and gene
therapy companies to get into the clinic faster.
Located in Hollister, California, the Company’s state-of-the-art
modular manufacturing facility recently received ISO 13485:2016
certification for the production of GMP-grade products. Previously
operational for research-grade production, the new facility adds
more than 10,000 square feet of GMP-certified ISO cleanrooms and
provides a three-fold increase in overall manufacturing
capacity.
“Our team has worked tirelessly over the past two years to build
our new GMP-certified production facility here in Hollister and its
opening represents a momentous milestone in our company’s
evolution,” said Stephen Gunstream, Teknova’s President and Chief
Executive Officer. “We kept hearing from our customers that they
wanted a partner who could support them with custom reagent
manufacturing as they scale from research, through process
development, and into clinical trials, particularly in batch
volumes of less than 2,000 liters. We built this facility to do
just that – in the city we’ve called home for almost 20 years – and
we look forward to leveraging our facility's modular manufacturing
capabilities to continue supporting our customers throughout
various stages of their lifecycle.”
“The San Benito County Chamber of Commerce is thrilled to
congratulate Teknova on the opening of their latest manufacturing
facility in Hollister, California,” said Michelle Leonard, Chief
Executive Officer of the San Benito County Chamber of Commerce. “As
a leading employer and long-time partner in the County, we’re
incredibly appreciative of the investment they continue to make in
Hollister, providing essential jobs to the area, and increasing our
visibility as a key location for the biotech and pharmaceutical
industry.”
With expanded formulation, dispensing, cleanroom, and warehouse
space – including increased automation to support single-use needs
and animal-free and endotoxin-controlled environments – the new
GMP-certified facility exemplifies Teknova’s modular manufacturing
platform, further enabling the flexible, scalable, and consistent
production of high-quality reagents that the Company is known for.
Bioprocessing and gene therapy companies are now able to work with
one trusted partner across the entire clinical pipeline,
accelerating their breakthroughs as they transition from RUO to
GMP.
For more information, or to schedule a tour of Teknova’s new,
GMP-certified facility, visit www.teknova.com/GMP.
ABOUT
TEKNOVA Teknova makes
solutions possible. Since 1996, Teknova has been innovating the
manufacture of critical reagents for the life sciences industry to
accelerate the discovery and development of novel therapies that
will help people live longer, healthier lives. We offer fully
customizable solutions for every stage of the workflow, supporting
industry leaders in cell and gene therapy, molecular diagnostics,
and synthetic biology. Our fast turnaround of high-quality agar
plates, microbial culture media, buffers and reagents, and water
helps our customers scale seamlessly from RUO to GMP. Headquartered
in Hollister, California, with over 200,000 square feet of
state-of-the-art facilities, Teknova’s modular manufacturing
platform was designed by our team of scientists, engineers, and
quality control experts to efficiently produce the foundational
ingredients for the discovery and commercialization of novel
therapies.
Investor Contacts
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Sara Michelmore
MacDougall Advisors
smichelmore@macdougall.bio
+1 781-235-3060
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
Grafico Azioni Alpha Teknova (NASDAQ:TKNO)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Alpha Teknova (NASDAQ:TKNO)
Storico
Da Lug 2023 a Lug 2024